At a glance
ClinicalIndex Comparison RecordN/ACompleted· 76 enrolled
Drug / intervention
Bard® LifeStent® Vascular Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bard® LifeStent® Vascular Stent Delivery System Study
In Brief
A clinical study evaluating Bard® LifeStent® Vascular Stent System for Peripheral Vascular Disease. Completed, enrolled 76 participants across 8 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the effectiveness and safety of a new delivery system for the Bard® LifeStent® Vascular Stent System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease
CountriesAustria, Germany
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedAug 2010
Primary CompletionOct 2010
Study CompletionDec 2013
TodayJul 2026
First PostedAug 11, 2010
Enrollment StartJun 1, 2010
Primary CompletionOct 1, 2010
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.9 years ago
Interventions
Bard® LifeStent® Vascular Stent Systemdevice
Stent Implantation